Botanical species · safety record

Lygodium japonicum

The EFSA Compendium of Botanicals holds 3 constituent measurements for Lygodium japonicum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Lygodium japonicum (Thunb.) Sw.

3Constituent measurements
0Safety records
1Cited sources
38Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 38 licensed products naming Lygodium japonicum as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Herb
  • New material
  • Rhizome(s)
  • Spore(s)
  • Spores

What the records describe

Constituents measured

  • Naphthalene derivatives1
  • Naphthoquinones1
  • P-coumaric acid1

Plant parts

  • Roots and other underground parts3

Preparations

  • Solvent extraction1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Naphthalene derivativesRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier
NaphthoquinonesRoots and other underground partsUnspecifiedNo resolvable identifier
P-coumaric acidRoots and other underground partsUnspecifiedNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Zhang, Guo-Gang., He, Ying-Cui., Liu, Hong-Xia., Zhu, Lin-Xia., Chen, Li-Juan., Olimat, Suleiman M. The research of Lygodium. Drug discovery research in pharmacognosy, 2012, p. 77-106.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue